CHIP Faculty Member Awarded Grant to Study Racial Disparity in Prescription of Anticoagulants and Future Risk of Thromboembolic Stroke in Patient with Atrial Fibrillation
Bristol-Myers Squibb and Pfizer awarded CHIP Faculty Member Yacob Tedla, PhD, a grant to investigate determinants of racial disparity in the prescription of oral anticoagulants and future risk of thromboembolic stroke in patients newly diagnosed with atrial fibrillation.
Oral anticoagulation reduces thromboembolic events associated with atrial fibrillation, yet 50% of patient with atrial fibrillation are not prescribed anticoagulants. Recent studies, including preliminary findings of the research team, showed significant racial disparities in the prescribing of anticoagulants, even after accounting for access to care, health insurance, and stroke risk factors.
The study will evaluate new factors that explain anticoagulant under-prescription, racial disparities in the prescription of anticoagulants, and incidence of stroke among patients newly diagnosed with atrial fibrillation.
Co-Investigators include CHIP Director Abel Kho, MD, Northwestern Medicine Harry W. Dingman Professor of Cardiology Philip Greenland, MD, and Northwestern Medicine Center for Arrhythmia Research Director and Jules J. Reingold Professor of Electrophysiology Rod Passman, MD.
Learn more about the study on the project page.